![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_45132d864d2b45c655e5656779f071a3.svg) | PI-103 | IC50 | 8.7 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_160a29879cd73d7dd09660bb28cdf816.svg) | Pictilisib | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_160a29879cd73d7dd09660bb28cdf816.svg) | Pictilisib | Ki | 2.6 [1], 10.2 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6603a475932cb1632b1b43c2f664a423.svg) | 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6603a475932cb1632b1b43c2f664a423.svg) | 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Ki | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_d257fc0c25c0c6e2c60c6a220511d065.svg) | 4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_98871935c6dbd53bec1df41a5db7ba4b.svg) | Dactolisib | IC50 | 16.4 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_80f534f1ba1e8231071ce6b7de9f8a21.svg) | Idelalisib | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2370402f8a6e3bb628c80ef4783fd95f.svg) | Buparlisib | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2370402f8a6e3bb628c80ef4783fd95f.svg) | Buparlisib | Ki | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_ac9222422aa3967de001af41e8ffd43b.svg) | Wortmannin | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_ac9222422aa3967de001af41e8ffd43b.svg) | Wortmannin | Ki | 120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_d472d7090a10696dcf0b9f871e2dfba5.svg) | Alpelisib | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_3d80a19ba1e2620217698d4f64071c64.svg) | Tgx-221 | IC50 | 5700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_4a8e767e222095576a2413305372544f.svg) | (2S)-1-N-[5-(2-Tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_b639199d264e69918c250f56e1a220e9.svg) | N-[(E)-(5-Cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide | IC50 | 0.9 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_b8ebc8fbae87ec4c84765ac6d6a46422.svg) | 6-(2-Aminopyrimidin-5-yl)-N-(2-methoxyethyl)-3-methyl-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide | IC50 | 0.9 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_b8ebc8fbae87ec4c84765ac6d6a46422.svg) | 6-(2-Aminopyrimidin-5-yl)-N-(2-methoxyethyl)-3-methyl-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide | Ki | 1.9 [1], 2.3 [2], 2.4 [3], 3.1 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_42da565d6abd302429bbe5a0af0dc3c6.svg) | PF-04691502 | IC50 | 3.3 [1], 4.85 [2], 8.33 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_42da565d6abd302429bbe5a0af0dc3c6.svg) | PF-04691502 | Ki | 0.57 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_32fbf8e753a5d3890996c15d29629ff9.svg) | Gedatolisib | IC50 | 0.4 [1], 0.6 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5e6b647e25dc5fdb97c02bfddfc2e634.svg) | Taselisib | IC50 | 0.7 [1], 4.0 [2], 31.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5e6b647e25dc5fdb97c02bfddfc2e634.svg) | Taselisib | Ki | 0.29 [1], 0.3 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_996e08d876789da3bd7ec24026b31a97.svg) | (2S)-N1-[5-(2-Tert-butyl-4-thiazolyl)-4-methyl-2-thiazolyl]pyrrolidine-1,2-dicarboxamide | IC50 | 15.0 [1], 32.0 [2], 200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2c2fffdcc3734b0005091da848fe6890.svg) | N-[(E)-(5-Cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-(2-hydroxyethyl)-2-methyl-5-nitrobenzenesulfonamide | IC50 | 0.8 [1], 1.3 [2], 49.0 [3], 82.0 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_a4ad40904ecb002c365de2fcab6b3376.svg) | N-{6-[6-Amino-5-(Trifluoromethyl)pyridin-3-Yl]imidazo[1,2-A]pyridin-2-Yl}acetamide | IC50 | 3.6 [1], 4.0 [2], 5.9 [3], 12.0 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_48a9f52bded07df9430a438c22211dd7.svg) | 2-(Difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)benzimidazol-4-ol | IC50 | 0.12 [1], 0.53 [2], 0.83 [3], 1.3 [4], 2.9 [5] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_c9aca5652531dd0d1e4b3e643723ca66.svg) | 2-(Difluoromethyl)-3-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-7-methoxybenzimidazol-5-amine | IC50 | 0.95 [1], 1.0 [2], 3.1 [3], 4.8 [4], 8.8 [5] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_57f7c3ea621ba6ff2e628118aec7be2b.svg) | 4-[4-[4-(Difluoromethoxy)-2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine | IC50 | 3.0 [1], 4.7 [2], 8.5 [3], 418.0 [4], 427.0 [5] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_a669ebb56459043c56643af797c73717.svg) | 2-(Difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-5-methoxybenzimidazol-4-ol | IC50 | 49.0 [1], 70.0 [2], 158.0 [3], 378.0 [4], 583.0 [5] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_604c791b9d1d3a87b364c41b1774336c.svg) | 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one | IC50 | 100000.0 [1], 200000.0 [2], 255000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_978c9a671f0ab948d6f4c61f7a205a19.svg) | Omipalisib | IC50 | 0.04 [1], 0.55 [2], 0.63 [3], 1.1 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_70587fa0659be3f28c8a2050d45e9fc9.svg) | N-[6-[6-Chloro-5-[[(4-fluorophenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide | IC50 | 6.3 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_70587fa0659be3f28c8a2050d45e9fc9.svg) | N-[6-[6-Chloro-5-[[(4-fluorophenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide | Ki | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6a128ea299a9f7657caade2822bdee2e.svg) | CID 46927938 | IC50 | 8.3 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6a128ea299a9f7657caade2822bdee2e.svg) | CID 46927938 | Ki | 1.77 [1], 1.89 [2], 2.33 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_00c342f2655f88e541c2e2ef586d412b.svg) | (3-(9-(1-Benzylpiperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol | IC50 | 45.0 [1], 63.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_d9e56d1809d5489ce49e6d478fb39e2a.svg) | N-(2-Chlorophenyl)-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide | IC50 | 16.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_d9e56d1809d5489ce49e6d478fb39e2a.svg) | N-(2-Chlorophenyl)-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide | Ki | 16.0 [1], 16.3 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_24a57548936f014e2987d819e2b6731e.svg) | 8-[(3,5-Difluoro-N-methylanilino)methyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide | IC50 | 10.0 [1], 25.0 [2], 850.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_69323feaf791fe1160a03639293049ed.svg) | [(3S)-3-[[6-(6-Methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone | IC50 | 1940.0 [1], 2037.8 [2], 2038.0 [3], 6490.0 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_c1a09447413c45370d7900a2185f7a32.svg) | 2-[4-[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]pyrazol-1-yl]ethanol | IC50 | 0.5 [1], 16.0 [2], 24.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_c1a09447413c45370d7900a2185f7a32.svg) | 2-[4-[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]pyrazol-1-yl]ethanol | Ki | 0.27 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_f62677f85cecfa0149202ce8e484a59f.svg) | 2-[1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-4,5-Dihydrothieno[3,2-D][1]benzoxepine-8-Carboxamide | IC50 | 4.0 [1], 155.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_8e91a91636d3d06c84054ea253d02ed8.svg) | 1-[4-[3-[6-(6-Methoxypyridin-3-yl)quinazolin-4-yl]benzoyl]piperazin-1-yl]ethanone | IC50 | 418.0 [1], 2120.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_037a3fbf1f3f9312945b4476f678c244.svg) | 5-{4-[3-(4-Acetylpiperazine-1-Carbonyl)phenyl]quinazolin-6-Yl}-2-Methoxypyridine-3-Carbonitrile | IC50 | 262.0 [1], 3440.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_7bea7ad885510aa2fa34f20391915c03.svg) | 5-[5-Chloro-2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine | IC50 | 5.2 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_7bea7ad885510aa2fa34f20391915c03.svg) | 5-[5-Chloro-2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine | Ki | 1.73 [1], 2.77 [2], 3.07 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_ec56576e238e48bad24017fb5fc967f7.svg) | 5-(6-Morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)benzene-1,3-diol | IC50 | 5.9 [1], 53.4 [2], 61.3 [3], 139.8 [4] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_020b6857f8c252df41bc602b24cd6d1e.svg) | 2-(Morpholin-4-yl)-benzo[h]chromen-4-one | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_375723c4a9d1079c63e87796be774461.svg) | 8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one | IC50 | 130.0 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_0161179f2c7cfb11abb7ada9cb7db29a.svg) | Apitolisib | IC50 | 4.8 [1], 5.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_0161179f2c7cfb11abb7ada9cb7db29a.svg) | Apitolisib | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_9e9011e9e6466a8a4aebc2f3c9b52cca.svg) | Pik-75 | IC50 | 0.5 [1], 7.8 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_dd5812d7d5c3575e93d5222ce3b5375f.svg) | 1-[4-(3-Ethyl-7-morpholin-4-yltriazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-[4-(4-methylpiperazine-1-carbonyl)phenyl]urea | IC50 | 1.0 [1], 1.4 [2], 2.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_94de714e75f90a7a2c9c250966a594b8.svg) | N-(7,8-Dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_ded02b65ef1463fae313a11911c40144.svg) | 1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 52.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_73bc9310a28387e84e894ffe9d61f0fa.svg) | Leniolisib | IC50 | 244.0 [1], 262.0 [2], 1670.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_bada19a1327cd523a6a347eb625a6ce2.svg) | CID 118502708 | IC50 | 320.0 [1], 1400.0 [2], 1410.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6e737d4108ad3bb1cffa3d9228e43f45.svg) | CID 46244454 | IC50 | 13000.0 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_8d06afb0ceb0006d4b21d994b6f44d7b.svg) | 5-(2-Morpholin-4-Yl-7-Pyridin-3-Yl-6,7-Dihydro-5h-Pyrrolo[2,3-D]pyrimidin-4-Yl)-Pyrimidin-2-Ylamine | IC50 | 33.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_84436b5f9b5ed74909f2dc257b8249a7.svg) | 3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | IC50 | 2.0 [1], 8.0 [2], 41.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_ca257b22c8fca4535d014f435bdaba7d.svg) | 1-Methyl-3-[4-[4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]urea | IC50 | 41.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_71f5b921eeca0e24aa13ffa09b5c6b99.svg) | Methyl 4-[6-[4-(methylcarbamoylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_a95af50d754518168c9c3a14f15d1b1c.svg) | 5-[6-[(4-Methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]pyrimidin-2-amine | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_552cd1aee72cac21d41b5f37eff8560c.svg) | N-[5-(2-Amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide | IC50 | 2.0 [1], 3.59 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_f3ba3bbb75e103002a0b0e362beefe7f.svg) | 9-(1-Anilinoethyl)-N,N-dimethyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide | IC50 | 560.0 [1], 2500.0 [2], 9600.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_d73ec0c6267438a341c27d8ff28bc0c5.svg) | 9-(1-Anilinoethyl)-N-[2-(dimethylamino)ethyl]-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide | IC50 | 370.0 [1], 2200.0 [2], 2300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5d1d45db662cdb23b8dd95beac3892ed.svg) | 1-[4-[4-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]pyrazol-1-yl]piperidin-1-yl]-2-(dimethylamino)ethanone | IC50 | 16.0 [1], 58.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5236e5b27d022b96a990c1005d154207.svg) | 2-[(1-Methyl-1h-Benzimidazol-2-Yl)methyl]-6-Morpholin-4-Ylpyrimidin-4(3h)-One | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_030075913fb2f62a28a1225b5c1dbe77.svg) | 2-N-(2-Chlorophenyl)-2-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide | IC50 | 1.5 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_030075913fb2f62a28a1225b5c1dbe77.svg) | 2-N-(2-Chlorophenyl)-2-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide | Ki | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5c6aeda82d659eae912c8d236d1358a9.svg) | 6-(1H-Indazol-4-yl)-1-methyl-4-(4-(methylsulfonyl)phenoxy)-1H-pyrazolo[3,4-b]pyridine | IC50 | 6.8 [1], 7.0 [2], 187.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_68d9e54f3cb971a8764dc9a285b754c6.svg) | 2-N-[2-Chloro-4-(dimethylcarbamoyl)phenyl]-2-N,8-N-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide | IC50 | 2.0 [1], 4.6 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_68d9e54f3cb971a8764dc9a285b754c6.svg) | 2-N-[2-Chloro-4-(dimethylcarbamoyl)phenyl]-2-N,8-N-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_47986356c345c93255ae0740662753cc.svg) | N-[5-(1,3-Benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide | IC50 | 769.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_47986356c345c93255ae0740662753cc.svg) | N-[5-(1,3-Benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide | Ki | 12.9 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2ebc587037b09710ff3b18773095c730.svg) | N-[5-(2-Amino-1,3-benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide | IC50 | 44.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2ebc587037b09710ff3b18773095c730.svg) | N-[5-(2-Amino-1,3-benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide | Ki | 5.6 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_f3b613365f6ea7f5adc8d2e17dcb140b.svg) | 5,5-Dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one | IC50 | 975.0 [1], 1333.0 [2], 2939.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_beae06cfeb7d588d17574cbabc3ddb9a.svg) | (2S)-2-Amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-3-phenylpropan-1-one | IC50 | 4700.0 [1], 8100.0 [2], 12000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_3460204edf5d34f88cc71be3b5b1c907.svg) | (2S)-2-Amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]propan-1-one | IC50 | 2300.0 [1], 3500.0 [2], 8200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_0e53cd069c2c0acafbe7679a18d13539.svg) | 2-[(3S)-3-(1H-Indol-3-ylmethyl)morpholin-4-yl]-7,7-dimethyl-6,8-dihydro-5H-[1,3]thiazolo[5,4-c]azepin-4-one | IC50 | 59.0 [1], 199.0 [2], 1412.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_b6c8146e902460c6adca447fdb262663.svg) | [(3S)-3-[[6-[6-Methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone | IC50 | 589.0 [1], 590.0 [2], 3550.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_3781a0624e90b62f8e5da3d1ba25444f.svg) | 1-[(3S)-3-[[6-[6-Methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]propan-1-one | IC50 | 791.0 [1], 792.0 [2], 2600.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_c9997786495a74c310910b15ab931900.svg) | 1-[(3S)-3-[[6-(6-Methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one | IC50 | 651.0 [1], 7410.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_657b2dbdf003a6df1686bfe5bf0ad24b.svg) | [(3S)-3-[[6-(6-Methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone | IC50 | 373.0 [1], 432.0 [2], 6190.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_6340f8a034a7609a0acf33e1dbc397bc.svg) | [(3S)-3-[[6-[6-Methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone | IC50 | 43.0 [1], 44.0 [2], 2150.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_5eccc52db8649f2403b8e8ed0062ecdf.svg) | (2S,3S)-2-Amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-3-methylpentan-1-one | IC50 | 2800.0 [1], 6300.0 [2], 9200.0 [3] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_f694aeab9655daf2c20e32989cebd2c7.svg) | Benzoin | IC50 | 2120000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_a257c791d1de1df5d4a1fa04612f9c76.svg) | Nvp-aew541 | IC50 | 9000.0 [1], 9100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_54176be475bbe83bc6b71c562b1599c7.svg) | Ku-0063794 | IC50 | 8900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_8b4f605fc7a6bc0f8889d7c35671a1cf.svg) | Copanlisib | IC50 | 0.5 [1], 0.7 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_e8d518d6d510c4ae182299c291ebca78.svg) | BGT-226 free base | IC50 | 4.0 [1], 41.91 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_a474a73200301d26a1703ccc54f7d7f9.svg) | 2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid | IC50 | 870.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_22781c1583dc405db11f622640299ba1.svg) | AS-252424 | IC50 | 940.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_0a6b3bd2f7b03aebd3cdd3ed0532a219.svg) | Azd-8186 | IC50 | 35.0 [1], 752.0 [2] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_27d3a5b4d06517b7e7f7d0e79a2b07e5.svg) | CID 44219749 | IC50 | 1026.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_2d88d466cb23432caa29391ef1120590.svg) | Liphagal | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/pi3-kinase-p110-alpha-subunit_b69a762055e99898f02252a88998dc70.svg) | Gne-477 | IC50 | 4.0 [1] |